-
1
-
-
34247104078
-
-
Lorusso R, De Cicco G, Beghi C, Gherli T, Poli E, Corradi D., et al. Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG. International Journal of Cardiology (in press).
-
-
-
-
2
-
-
0025694966
-
History of aspirin and its mechanism of action
-
Vane J.R., Flower R.J., and Botting R.M. History of aspirin and its mechanism of action. Stroke 21 12 Suppl (1990) IV12-IV23
-
(1990)
Stroke
, vol.21
, Issue.12 SUPPL
-
-
Vane, J.R.1
Flower, R.J.2
Botting, R.M.3
-
3
-
-
0034638656
-
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis
-
Derry S., and Loke Y.K. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 321 7270 (2000) 1183-1187
-
(2000)
BMJ
, vol.321
, Issue.7270
, pp. 1183-1187
-
-
Derry, S.1
Loke, Y.K.2
-
4
-
-
0035124920
-
Platelet-active drugs: the relationships among dose, effectiveness, and side effects
-
Patrono C., Coller B., Dalen J.E., FitzGerald G.A., Fuster V., Gent M., et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 119 1 Suppl (2001) 39S-63S
-
(2001)
Chest
, vol.119
, Issue.1 SUPPL
-
-
Patrono, C.1
Coller, B.2
Dalen, J.E.3
FitzGerald, G.A.4
Fuster, V.5
Gent, M.6
-
5
-
-
28244459634
-
Low-dose aspirin for the prevention of atherothrombosis
-
Patrono C., Garcia Rodriguez L.A., Landolfi R., and Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 22 (2005) 2373-2383
-
(2005)
N Engl J Med
, vol.353
, Issue.22
, pp. 2373-2383
-
-
Patrono, C.1
Garcia Rodriguez, L.A.2
Landolfi, R.3
Baigent, C.4
-
7
-
-
0028120906
-
Collaborative overview of randomised trials of antiplatelet therapy-I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration
-
Collaborative overview of randomised trials of antiplatelet therapy-I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 308 6921 (1994) 81-106
-
(1994)
BMJ
, vol.308
, Issue.6921
, pp. 81-106
-
-
-
8
-
-
0033577982
-
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
-
Wolfe M.M., Lichtenstein D.R., and Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340 24 (1999) 1888-1899
-
(1999)
N Engl J Med
, vol.340
, Issue.24
, pp. 1888-1899
-
-
Wolfe, M.M.1
Lichtenstein, D.R.2
Singh, G.3
-
9
-
-
0033868029
-
Nitric oxide in mucosal defense: a little goes a long way
-
Wallace J.L., and Miller M.J. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119 2 (2000) 512-520
-
(2000)
Gastroenterology
, vol.119
, Issue.2
, pp. 512-520
-
-
Wallace, J.L.1
Miller, M.J.2
-
10
-
-
0036562261
-
Potential cardioprotective actions of NO-releasing aspirin
-
Wallace J.L., Ignarro L.J., and Fiorucci S. Potential cardioprotective actions of NO-releasing aspirin. Nat Rev Drug Discov 1 5 (2002) 375-382
-
(2002)
Nat Rev Drug Discov
, vol.1
, Issue.5
, pp. 375-382
-
-
Wallace, J.L.1
Ignarro, L.J.2
Fiorucci, S.3
-
11
-
-
0343628040
-
A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate
-
Grosser N., and Schroder H. A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate. Biochem Biophys Res Commun 274 1 (2000) 255-258
-
(2000)
Biochem Biophys Res Commun
, vol.274
, Issue.1
, pp. 255-258
-
-
Grosser, N.1
Schroder, H.2
-
12
-
-
0034886127
-
Nitrosylhemoglobin, an unequivocal index of nitric oxide release from nitroaspirin: in vitro and in vivo studies in the rat by ESR spectroscopy
-
Carini M., Aldini G., Stefani R., Orioli M., and Facino R.M. Nitrosylhemoglobin, an unequivocal index of nitric oxide release from nitroaspirin: in vitro and in vivo studies in the rat by ESR spectroscopy. J Pharm Biomed Anal 26 4 (2001) 509-518
-
(2001)
J Pharm Biomed Anal
, vol.26
, Issue.4
, pp. 509-518
-
-
Carini, M.1
Aldini, G.2
Stefani, R.3
Orioli, M.4
Facino, R.M.5
-
13
-
-
33344467378
-
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives
-
Bolla M., Momi S., Gresele P., and Del Soldato P. Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. Eur J Clin Pharmacol 62 Suppl 13 (2006) 145-154
-
(2006)
Eur J Clin Pharmacol
, vol.62
, Issue.SUPPL. 13
, pp. 145-154
-
-
Bolla, M.1
Momi, S.2
Gresele, P.3
Del Soldato, P.4
-
14
-
-
0036778552
-
NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function
-
Fiorucci S., Mencarelli A., Mannucci R., Distrutti E., Morelli A., del Soldato P., et al. NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. FASEB J 16 12 (2002) 1645-1647
-
(2002)
FASEB J
, vol.16
, Issue.12
, pp. 1645-1647
-
-
Fiorucci, S.1
Mencarelli, A.2
Mannucci, R.3
Distrutti, E.4
Morelli, A.5
del Soldato, P.6
-
15
-
-
0034664922
-
l-Arginine in coronary atherosclerosis
-
Tentolouris C., Tousoulis D., Goumas G., Stefanadis C., Davies G., and Toutouzas P. l-Arginine in coronary atherosclerosis. Int J Cardiol 75 2-3 (2000) 123-128
-
(2000)
Int J Cardiol
, vol.75
, Issue.2-3
, pp. 123-128
-
-
Tentolouris, C.1
Tousoulis, D.2
Goumas, G.3
Stefanadis, C.4
Davies, G.5
Toutouzas, P.6
-
16
-
-
8344222641
-
Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia
-
Emanueli C., Van Linthout S., Salis M.B., Monopoli A., Del Soldato P., Ongini E., et al. Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia. Arterioscler Thromb Vasc Biol 24 11 (2004) 2082-2087
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, Issue.11
, pp. 2082-2087
-
-
Emanueli, C.1
Van Linthout, S.2
Salis, M.B.3
Monopoli, A.4
Del Soldato, P.5
Ongini, E.6
-
17
-
-
4344677822
-
Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells
-
Muzaffar S., Shukla N., Angelini G., and Jeremy J.Y. Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells. Circulation 110 9 (2004) 1140-1147
-
(2004)
Circulation
, vol.110
, Issue.9
, pp. 1140-1147
-
-
Muzaffar, S.1
Shukla, N.2
Angelini, G.3
Jeremy, J.Y.4
-
18
-
-
0037022334
-
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis
-
Napoli C., Aldini G., Wallace J.L., de Nigris F., Maffei R., Abete P., et al. Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis. Proc Natl Acad Sci U S A 99 3 (2002) 1689-1694
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.3
, pp. 1689-1694
-
-
Napoli, C.1
Aldini, G.2
Wallace, J.L.3
de Nigris, F.4
Maffei, R.5
Abete, P.6
-
19
-
-
0034858876
-
Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats
-
Muscara M.N., Lovren F., McKnight W., Dicay M., del Soldato P., Triggle C.R., et al. Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats. Br J Pharmacol 133 8 (2001) 1314-1322
-
(2001)
Br J Pharmacol
, vol.133
, Issue.8
, pp. 1314-1322
-
-
Muscara, M.N.1
Lovren, F.2
McKnight, W.3
Dicay, M.4
del Soldato, P.5
Triggle, C.R.6
-
20
-
-
4043182018
-
Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans
-
Fiorucci S., Mencarelli A., Meneguzzi A., Lechi A., Renga B., del Soldato P., et al. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. J Am Coll Cardiol 44 3 (2004) 635-641
-
(2004)
J Am Coll Cardiol
, vol.44
, Issue.3
, pp. 635-641
-
-
Fiorucci, S.1
Mencarelli, A.2
Meneguzzi, A.3
Lechi, A.4
Renga, B.5
del Soldato, P.6
-
21
-
-
11844288393
-
Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials
-
Okrainec K., Platt R., Pilote L., and Eisenberg M.J. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol 45 2 (2005) 177
-
(2005)
J Am Coll Cardiol
, vol.45
, Issue.2
, pp. 177
-
-
Okrainec, K.1
Platt, R.2
Pilote, L.3
Eisenberg, M.J.4
|